Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/10/2025 ,inter alia, to consider and approve a. Consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2025. b. Declaration of an Interim Dividend on the equity shares of the Company, for the Financial Year 2025-26; and c. Proposal for issue of bonus shares, in accordance with the applicable provisions of the Companies Act, 2013 (including the rules framed thereunder), and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, and subject to requisite approval.